Navigation Links
Discovery increases understanding how bacteria spread: U of A study
Date:6/20/2012

A University of Alberta researcher is moving closer to understanding how infection is caused by the spread of bacteria.

In a study published in the high-impact Cell Press journal called Structure, Joel Weiner and his collaborators, Gerd Prehna and Natalie Stynadka at the University of British Columbia, share new knowledge about how bacteria release proteins.

Proteins are complex molecules that perform all sorts of functions in the cells of living things. The group studied a specific protein called YebF in E. coli bacteria. It is widely found in other bacteria as well.

Solving the structure and understanding the mechanism by which this protein spreads bacterial pathogens was a big step forward. As humans develop more resistance to antibiotics, researchers are in search of new ways to stop bacteria from spreading.

"Most pathogenic bacteria induce special structures in order to release proteins that allow them to infect a host," said Weiner of the Department of Biochemistry, whose lab is funded by the Natural Sciences & Engineering Research Council and the Canadian Institutes of Health Research. "What we show here is that normal, run-of-the-mill bacteria can actually release a protein through the pores [of the bacterial membrane] which are normally there to take in small molecules."

YebF proved to be an interesting protein molecule because in addition to its release through the bacterial pore, which is the most recent discovery, it has the unique property of secreting "passenger proteins" that are attached to it. This unique property was a prior discovery patented by the U of A because it has potential use for the production of protein-based drugs by the pharmaceutical and biotechnology industry.

"What we found in the structure is that there are regions that are very flexible in YebF that seem to be very important in getting it out of the bacteria," said Weiner. "If you make mutants in those regions you can prevent the protein from going out.

"We're not investing enough in identifying new targets for antibiotics," he said. "What this system does suggests a new target. We're looking at drugs that could block the ability of YebF to go out.

"That's really easy to test for," he added. Because the screen is easy, it's good for pharmaceutical companies."

This step in the research took several years, because solving the structure of this protein wasn't easy. The lab typically uses crystallization but stubborn YebF wouldn't work, so instead they had to use nuclear magnetic resonance.

Typically researchers know what action takes place and they try to find the protein that triggers it. In this case the researchers have been working the opposite direction. They have the protein, YebF, but they need to find out its purpose in the cell.


'/>"/>

Contact: Quinn Phillips
quinn.phillips@ualberta.ca
780-248-2048
University of Alberta Faculty of Medicine & Dentistry
Source:Eurekalert

Related biology news :

1. NSF Leadership in Discovery and Innovation sparks White House US Ignite Initiative
2. Groundbreaking discovery of the cellular origin of cervical cancer
3. Astellas and DNDi to collaborate on new drug discovery research for the treatment of NTDs
4. New discovery provides insight on long-standing pregnancy mystery
5. Speeding up drug discovery with rapid 3-D mapping of proteins
6. La Jolla Institute discovery could lead to new way to screen drugs for adverse reactions
7. A whale of a discovery: New sensory organ found in rorqual whales
8. Novel discovery by NUS scientists paves the way for more effective treatment of cancers
9. Discovery of mechanisms predicting response to new treatments in colon cancer
10. DNA barcoding verified the discovery of a highly disconnected crane fly species
11. Understanding the RNAi Reagents Market Overlap with Drug Discovery and Therapeutic Development is Critical for Pharmaceutical Leaders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/29/2017)... , March 29, 2017  higi, the health IT ... North America , today announced a ... the acquisition of EveryMove. The new investment and acquisition ... of tools to transform population health activities through the ... data. higi collects and secures data today ...
(Date:3/24/2017)... , Mar 24, 2017 Research and ... Access System Market Analysis & Trends - Industry Forecast to 2025" ... ... to grow at a CAGR of around 15.1% over the next ... This industry report analyzes the market estimates and forecasts for all ...
Breaking Biology News(10 mins):
(Date:6/22/2017)... ... 21, 2017 , ... RMC Pharmaceutical Solutions, Inc. announces the ... to manage the new site. , Tim has 25 years of pharmaceutical experience, ... role as the Director of Manufacturing and Supplier Quality Assessment. This group ...
(Date:6/22/2017)... ANGELES, CA (PRWEB) , ... June 22, 2017 ... ... with global health leaders in designating infertility as a disease, bringing new hope ... last week at their 2017 annual meeting to back the World Health Organization’s ...
(Date:6/22/2017)... ... June 22, 2017 , ... The first human cell line HeLa, ... the first data on cross-contamination of human cell lines with HeLa cells were published. ... in cell culture labs and is associated with dramatic consequences for research. , ...
(Date:6/20/2017)... ... June 20, 2017 , ... CTNext ... of directors has formed a Higher Education Entrepreneurship Advisory Committee to implement the ... presidents and other high-ranking representatives from 35 higher education institutions across the state ...
Breaking Biology Technology: